In an article, Dr. Jasenka Piljac Zegarac summarizes Dr. Pashtoon M. Kasi and colleagues’ findings related to ctDNA testing and well-being in CRC patients, which were presented at the 2024 ASCO Gastrointestinal Cancers Symposium.

“ctDNA should be viewed as one added (and probably one of the most powerful) tool in the toolbox instead of a standalone variable.”—Dr. Pashtoon M. Kasi